Clinical Trial Update: Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab as salvage therapy in patients with wild-type RAS/RAF metastatic colorectal cancer with liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Hôpital Franco-Britannique-Fondation Cognacq-Jay | Conditions: Cancer Colorectal | Phase 2 | Status: UNKNOWN